| 000 | 01110 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512045929.0 | ||
| 264 | 0 | _c19880314 | |
| 008 | 198803s 0 0 eng d | ||
| 022 | _a0304-3959 | ||
| 024 | 7 |
_a10.1016/0304-3959(88)90018-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFine, P G | |
| 245 | 0 | 0 |
_aThe effects of myofascial trigger point injections are naloxone reversible. _h[electronic resource] |
| 260 |
_bPain _cJan 1988 |
||
| 300 |
_a15-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBupivacaine _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEndorphins _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyofascial Pain Syndromes _xdrug therapy |
| 650 | 0 | 4 | _aNaloxone |
| 650 | 0 | 4 | _aRandom Allocation |
| 700 | 1 | _aMilano, R | |
| 700 | 1 | _aHare, B D | |
| 773 | 0 |
_tPain _gvol. 32 _gno. 1 _gp. 15-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0304-3959(88)90018-8 _zAvailable from publisher's website |
| 999 |
_c3346170 _d3346170 |
||